ReviewJournal of obesity & metabolic syndrome2026
Evaluating the Safety Profile of Glucagon-Like Peptide-1 Receptor Agonists: Adverse Events and Clinical Recommendations.
Mi Kyung Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.